Skip to main content
Erschienen in: Pediatric Cardiology 8/2017

21.08.2017 | Original Article

Serum Resistin Negatively Correlates with Clinical Severity of Postural Tachycardia Syndrome in Children

verfasst von: Wei Bai, Zhenhui Han, Siyao Chen, Hongxia Li, Jingyuan Song, Jianguang Qi, Ying Liao, Chaoshu Tang, Ping Liu, Yuli Wang, Hongfang Jin, Junbao Du

Erschienen in: Pediatric Cardiology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

This study was designed to analyse the serum resistin level in children with postural tachycardia syndrome (POTS) and its clinical significance. Twenty-one children with POTS and 31 healthy children as controls participated in the study. Clinical characteristics, heart rate and blood pressure in the supine and upright positions were monitored and collected during an upright test, and the symptom scoring of POTS patients was recorded. The serum resistin levels of patients in both groups were determined by enzyme-linked immunosorbent assay. The change in serum resistin levels in the POTS group before and after standing, as well as its correlation with symptom scores and change in heart rate after standing, was analysed. Compared with the control group, the serum resistin levels in the POTS group were significantly increased (P < 0.01). The serum resistin levels in the POTS group before and after standing did not differ (P > 0.05). There was a negative correlation between the serum resistin levels and a change in heart rate from the supine to upright position (correlation coefficient = −0.615, P < 0.01). Moreover, serum resistin levels were negatively correlated with symptom scores (correlation coefficient = −0.493, P < 0.05). Serum resistin levels in children with POTS were significantly higher than those in healthy children and negatively correlated with a change in heart rate from the supine to upright position and symptom scores. These results suggest a protective role of increased resistin in the pathogenesis of POTS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lin J, Han Z, Li X, Ochs T, Zhao J, Zhang X et al (2014) Risk factors for postural tachycardia syndrome in children and adolescents. PLoS ONE 9:e113625–e113625CrossRefPubMedPubMedCentral Lin J, Han Z, Li X, Ochs T, Zhao J, Zhang X et al (2014) Risk factors for postural tachycardia syndrome in children and adolescents. PLoS ONE 9:e113625–e113625CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Fu Q, VanGundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL et al (2010) Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol 55:2858–2868CrossRefPubMedPubMedCentral Fu Q, VanGundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL et al (2010) Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol 55:2858–2868CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Elsayed H (1996) Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75:134–140CrossRef Elsayed H (1996) Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75:134–140CrossRef
4.
Zurück zum Zitat Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK (2009) Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 20:352–358CrossRefPubMedPubMedCentral Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK (2009) Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 20:352–358CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Zhang Q, Liao Y, Tang C, Du J, Jin H (2012) Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome. J Pediatr 161:281–284CrossRefPubMed Zhang Q, Liao Y, Tang C, Du J, Jin H (2012) Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome. J Pediatr 161:281–284CrossRefPubMed
6.
Zurück zum Zitat Jordan J, Shannon JR, Diedrich A, Black BK, Robertson D (2002) Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension 39:173–178CrossRefPubMed Jordan J, Shannon JR, Diedrich A, Black BK, Robertson D (2002) Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension 39:173–178CrossRefPubMed
7.
Zurück zum Zitat Zhang Q, Xia C, Li J, Du J (2014) Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome. J Translat Med 12:1–6CrossRef Zhang Q, Xia C, Li J, Du J (2014) Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome. J Translat Med 12:1–6CrossRef
8.
Zurück zum Zitat Wang XL, Chai Q, Charlesworth MC, Figueroa JJ, Low P, Shen WK et al (2012) Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Proteom Clin Appl 6:615–625CrossRef Wang XL, Chai Q, Charlesworth MC, Figueroa JJ, Low P, Shen WK et al (2012) Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Proteom Clin Appl 6:615–625CrossRef
9.
Zurück zum Zitat Yu X, Stavrakis S, Hill MA, Huang S, Reim S, Li H et al (2012) Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an “autoimmune” orthostatic hypotension. J Am Soc Hypertens 6:40–47CrossRefPubMed Yu X, Stavrakis S, Hill MA, Huang S, Reim S, Li H et al (2012) Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an “autoimmune” orthostatic hypotension. J Am Soc Hypertens 6:40–47CrossRefPubMed
10.
Zurück zum Zitat Wang XL, Ling TY, Charlesworth MC, Figueroa JJ, Low P, Shen WK et al (2013) Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome. Trans Res 162:34–44CrossRef Wang XL, Ling TY, Charlesworth MC, Figueroa JJ, Low P, Shen WK et al (2013) Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome. Trans Res 162:34–44CrossRef
11.
Zurück zum Zitat Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S et al (2007) Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc 82:308–313CrossRefPubMed Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S et al (2007) Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc 82:308–313CrossRefPubMed
12.
Zurück zum Zitat Liao Y, Chen S, Liu X, Zhang Q, Ai Y, Wang Y et al (2010) Flow-Mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome. Am J Cardiol 106:378–382CrossRefPubMed Liao Y, Chen S, Liu X, Zhang Q, Ai Y, Wang Y et al (2010) Flow-Mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome. Am J Cardiol 106:378–382CrossRefPubMed
13.
Zurück zum Zitat Zhang F, Li X, Ochs T, Chen L, Liao Y, Tang C et al (2012) Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. J Am Coll Cardiol 60:315–320CrossRefPubMed Zhang F, Li X, Ochs T, Chen L, Liao Y, Tang C et al (2012) Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. J Am Coll Cardiol 60:315–320CrossRefPubMed
14.
Zurück zum Zitat Zhang F, Li X, Chen S, Chen L, Liao Y, Tang C et al (2012) Plasma hydrogen sulfide in differential diagnosis between vasovagal syncope and postural orthostatic tachycardia syndrome in children. J Pediatr 160:227–231CrossRefPubMed Zhang F, Li X, Chen S, Chen L, Liao Y, Tang C et al (2012) Plasma hydrogen sulfide in differential diagnosis between vasovagal syncope and postural orthostatic tachycardia syndrome in children. J Pediatr 160:227–231CrossRefPubMed
15.
Zurück zum Zitat Medow MS, Minson CT, Stewart JM (2005) Decreased microvascular nitric oxide–dependent vasodilation in postural tachycardia syndrome. Circulation 112:2611–2618CrossRefPubMedPubMedCentral Medow MS, Minson CT, Stewart JM (2005) Decreased microvascular nitric oxide–dependent vasodilation in postural tachycardia syndrome. Circulation 112:2611–2618CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Steppan CM, Bailey ST, Bhat S, Brown EJ et al (2001) The hormone resistin links obesity to diabetes. Nature 409:307–312CrossRefPubMed Steppan CM, Bailey ST, Bhat S, Brown EJ et al (2001) The hormone resistin links obesity to diabetes. Nature 409:307–312CrossRefPubMed
17.
Zurück zum Zitat Jamaluddin MS, Weakley SM, Yao Q, Chen C (2012) Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 165:622–632CrossRefPubMedPubMedCentral Jamaluddin MS, Weakley SM, Yao Q, Chen C (2012) Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 165:622–632CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Hs J, Kh P, Ym C, Ss C, Hj C, Sy C et al (2006) Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 69:76–85CrossRef Hs J, Kh P, Ym C, Ss C, Hj C, Sy C et al (2006) Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 69:76–85CrossRef
19.
Zurück zum Zitat Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL (2007) Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156:279CrossRefPubMed Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL (2007) Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156:279CrossRefPubMed
20.
Zurück zum Zitat Gamboa A, Okamoto LE, Raj SR, Diedrich A, Shibao CA, Robertson D et al (2013) Nitric oxide and regulation of heart rate in patients with postural tachycardia syndrome and healthy subjects. Hypertension 61:376–381CrossRefPubMedPubMedCentral Gamboa A, Okamoto LE, Raj SR, Diedrich A, Shibao CA, Robertson D et al (2013) Nitric oxide and regulation of heart rate in patients with postural tachycardia syndrome and healthy subjects. Hypertension 61:376–381CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Yang J, Zhao J, Du S, Liu D, Fu C, Li X et al (2013) Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride. J Pediatr 163(1169–1173):e1162 Yang J, Zhao J, Du S, Liu D, Fu C, Li X et al (2013) Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride. J Pediatr 163(1169–1173):e1162
22.
Zurück zum Zitat Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111:932–939CrossRefPubMed Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111:932–939CrossRefPubMed
23.
Zurück zum Zitat Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174:5789–5795CrossRefPubMed Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174:5789–5795CrossRefPubMed
24.
Zurück zum Zitat Calabro P, Samudio I, Willerson JT, Yeh ET (2004) Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110:3335–3340CrossRefPubMed Calabro P, Samudio I, Willerson JT, Yeh ET (2004) Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110:3335–3340CrossRefPubMed
25.
Zurück zum Zitat Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD et al (2003) Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108:736–740CrossRefPubMed Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD et al (2003) Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108:736–740CrossRefPubMed
26.
Zurück zum Zitat Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y et al (2004) Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine–endothelial cell interactions. Biochem Biophys Res Commun 314:415–419CrossRefPubMed Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y et al (2004) Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine–endothelial cell interactions. Biochem Biophys Res Commun 314:415–419CrossRefPubMed
27.
Zurück zum Zitat Sun Y, Tang CS, Jb DU, Jin HF (2011) Hydrogen sulfide and vascular relaxation. Chin Med J (Engl). 124:3816–3819PubMed Sun Y, Tang CS, Jb DU, Jin HF (2011) Hydrogen sulfide and vascular relaxation. Chin Med J (Engl). 124:3816–3819PubMed
28.
Zurück zum Zitat Li H, Liao Y, Han Z, Wang Y, Liu P, Zhang Q et al (2015) Changes of plasma intermedin during head-up tilt test in children with postural tachycardia syndrome and its significance. Zhonghua Er Ke Za Zhi 53:375–378PubMed Li H, Liao Y, Han Z, Wang Y, Liu P, Zhang Q et al (2015) Changes of plasma intermedin during head-up tilt test in children with postural tachycardia syndrome and its significance. Zhonghua Er Ke Za Zhi 53:375–378PubMed
29.
Zurück zum Zitat Fang C, Lei J, Zhou SX, Zhang YL, Yuan GY, Wang JF (2013) Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension. Zhonghua Er Ke Za Zhi 126:646–649 Fang C, Lei J, Zhou SX, Zhang YL, Yuan GY, Wang JF (2013) Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension. Zhonghua Er Ke Za Zhi 126:646–649
30.
Zurück zum Zitat Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M et al (2008) Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 51:534–539CrossRefPubMed Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M et al (2008) Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 51:534–539CrossRefPubMed
31.
Zurück zum Zitat Zhang L, Curhan GC, Forman JP (2010) Plasma resistin levels associate with risk for hypertension among nondiabetic women. J Am Soc Nephrol 21:1185–1191CrossRefPubMedPubMedCentral Zhang L, Curhan GC, Forman JP (2010) Plasma resistin levels associate with risk for hypertension among nondiabetic women. J Am Soc Nephrol 21:1185–1191CrossRefPubMedPubMedCentral
Metadaten
Titel
Serum Resistin Negatively Correlates with Clinical Severity of Postural Tachycardia Syndrome in Children
verfasst von
Wei Bai
Zhenhui Han
Siyao Chen
Hongxia Li
Jingyuan Song
Jianguang Qi
Ying Liao
Chaoshu Tang
Ping Liu
Yuli Wang
Hongfang Jin
Junbao Du
Publikationsdatum
21.08.2017
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 8/2017
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1708-4

Weitere Artikel der Ausgabe 8/2017

Pediatric Cardiology 8/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.